{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:42:50Z","timestamp":1776134570811,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02807-9","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T09:02:43Z","timestamp":1682413363000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anticoagulation practices and complications associated with Impella\u00ae support at an advanced cardiac center in the Middle East gulf region"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-3707","authenticated-orcid":false,"given":"Mohamed","family":"Hisham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam H.","family":"Ghalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-802X","authenticated-orcid":false,"given":"Bassam","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"1","key":"2807_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ccd.29434","volume":"99","author":"SN Nouri","year":"2022","unstructured":"Nouri SN, Malick W, Masoumi A et al (2022) Impella\u00ae percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: a retrospective analysis from a tertiary academic medical center. Catheter Cardiovasc Interv 99(1):37\u201347","journal-title":"Catheter Cardiovasc Interv"},{"key":"2807_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/eurheartj\/eht248","volume":"35","author":"K Werdan","year":"2014","unstructured":"Werdan K, Gielen S, Ebelt H et al (2014) Mechanical circulatory support in cardiogenic shock. Eur Heart J 35:156\u2013167","journal-title":"Eur Heart J"},{"issue":"19","key":"2807_CR3","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","volume":"52","author":"M Seyfarth","year":"2008","unstructured":"Seyfarth M, Sibbing D, Bauer I et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584\u20131588","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2807_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","volume":"69","author":"DM Ouweneel","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD et al (2017) Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69(3):278\u2013287","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2807_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","volume":"139","author":"B Schrage","year":"2019","unstructured":"Schrage B, Ibrahim K, Loehn T et al (2019) Impella\u00ae support for acute myocardial infarction complicated by cardiogenic shock. Circulation 139(10):1249\u20131258","journal-title":"Circulation"},{"key":"2807_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.jcin.2016.08.037","volume":"9","author":"BR Weil","year":"2016","unstructured":"Weil BR, Konecny F, Suzuki G, Iyer V, Canty JM Jr (2016) Comparative hemodynamic effects of contemporary percutaneous mechanical circulatory support devices in a porcine model of acute myocardial infarction. JACC Cardiovasc Interv 9:2292\u20132303","journal-title":"JACC Cardiovasc Interv"},{"key":"2807_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ccd.22263","volume":"75","author":"M Remmelink","year":"2010","unstructured":"Remmelink M, Sjauw KD, Henriques JP et al (2010) Effects of mechanical left ventricular unloading by Impella\u00ae on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 75:187\u2013194","journal-title":"Catheter Cardiovasc Interv"},{"key":"2807_CR8","unstructured":"Abiomed. Reinforcement for Purge Management Recommendations. Impella\u00ae Update February 2017. Volume 2021. Abiomed; 2017. http:\/\/abiomed-private.s3.amazonaws.com\/assets\/files\/14864898121bf5cc54722a9e59410f33c96eadb10a.pdf. Accessed July 19, 2022."},{"issue":"19","key":"2807_CR9","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jacc.2022.02.052","volume":"79","author":"C Vandenbriele","year":"2022","unstructured":"Vandenbriele C, Arachchillage DJ, Frederiks P et al (2022) Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock: JACC review topic of the week. J Am Coll Cardiol 79(19):1949\u20131962","journal-title":"J Am Coll Cardiol"},{"key":"2807_CR10","doi-asserted-by":"publisher","first-page":"3791307","DOI":"10.1155\/2019\/3791307","volume":"2019","author":"BN Reed","year":"2019","unstructured":"Reed BN, DiDomenico RJ, Allender JE et al (2019) Survey of anticoagulation practices with the Impella\u00ae percutaneous ventricular assist device at high-volume centers. J Interv Cardiol 2019:3791307","journal-title":"J Interv Cardiol"},{"issue":"4","key":"2807_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0897190018822105","volume":"33","author":"AS Newsome","year":"2020","unstructured":"Newsome AS, Taylor A, Garner S (2020) Anticoagulation of a percutaneous left ventricular assist Device. Using a low-dose heparin purge solution protocol: a case series. J Pharm Pract 33(4):471\u2013476","journal-title":"J Pharm Pract"},{"key":"2807_CR12","first-page":"101","volume":"67","author":"VDS Gilaman","year":"2021","unstructured":"Gilaman VDS, Popovsky M et al (2021) Bicarbonate as an alternative to heparin in Impella\u00ae purge fluid: understanding the biochemical basis. ASAIO J 67:101","journal-title":"ASAIO J"},{"key":"2807_CR13","unstructured":"Abiomed. 2017. 5% Dextrose with Heparin as Default Impella\u00ae Purge Solution. Impella\u00ae Update September 2015. Volume 2021: Abiomed. https:\/\/www.heartrecovery.com\/education\/education-library\/faq-anticoagulation. Accessed July 19, 2022."},{"key":"2807_CR14","unstructured":"Abiomed. 2022 Heparin Free purge. Impella\u00ae Update May 2022. Volume 2022: Abiomed. https:\/\/www.heartrecovery.com\/education\/education-library\/faq-anticoagulation. Accessed July 19, 2022."},{"issue":"9 Supplement","key":"2807_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0735-1097(22)01624-2","volume":"79","author":"C Beavers","year":"2022","unstructured":"Beavers C, Dunn S, DiDomenico R (2022) Bicarbonate-based purge solution during impella\u00ae support: a growing alternative. J Am Coll Cardiol 79(9 Supplement):633","journal-title":"J Am Coll Cardiol"},{"key":"2807_CR16","unstructured":"Abiomed. 2020. Anticoagulation Therapy with Impella\u00ae Heparin Infusion. Impella\u00ae Update February 2020. Volume 2020: Abiomed. https:\/\/www.heartrecovery.com\/resources\/downloads\/product-update-anti-coagulation-therapy-with-impella-heparin-infusion. Accessed July 19, 2022."},{"key":"2807_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/TA.0000000000000199","volume":"76","author":"M Fr\u00f6hlich","year":"2014","unstructured":"Fr\u00f6hlich M, Lefering R, Probst C et al (2014) Epidemiology and risk factors of multiple-organ failure after multiple trauma. J Trauma Acute Care Surg 76:921\u2013928","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"2807_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/CCM.0000000000000981","volume":"43","author":"ID Peltan","year":"2015","unstructured":"Peltan ID, Vande Vusse LK, Maier RV, Watkins TR (2015) An International normalized ratio-based definition of acute traumatic coagulopathy is associated with mortality, venous thromboembolism, and multiple organ failure after injury. Crit Care Med 43(7):1429\u20131438","journal-title":"Crit Care Med"},{"issue":"11","key":"2807_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/phar.2629","volume":"41","author":"CJ Beavers","year":"2021","unstructured":"Beavers CJ, DiDomenico RJ, Dunn SP et al (2021) Optimizing anticoagulation for patients receiving Impella\u00ae support. Pharmacotherapy 41(11):932\u2013942","journal-title":"Pharmacotherapy"},{"issue":"23","key":"2807_CR20","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123(23):2736\u20132747","journal-title":"Circulation"},{"key":"2807_CR21","unstructured":"Abiomed. Impella\u00ae Ventricular Support Systems for Use during Cardiogenic Shock and High-Risk PCI: Impella\u00ae 2.5, Impella\u00ae 5.0, Impella\u00ae LD, and Impella\u00ae CP (Shock); Impella\u00ae 2.5 and Impella\u00ae CP (HRPCI) Instructions for Use & Clinical Reference Manual. Abiomed; 2020. https:\/\/www.heartrecovery.com\/products-and-services\/Impella\u00ae. Accessed July 19, 2022."},{"issue":"1","key":"2807_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.athoracsur.2013.07.053","volume":"97","author":"A Lemaire","year":"2014","unstructured":"Lemaire A, Anderson MB, Lee LY et al (2014) The Impella\u00ae device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg 97(1):133\u2013138","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"2807_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","volume":"6","author":"A Lauten","year":"2013","unstructured":"Lauten A, Engstrom AE, Jung C et al (2013) Percutaneous left-ventricular support with the Impella\u00ae-2.5-assist device in acute cardiogenic shock: results of the Impella\u00ae-EUROSHOCK-Regis- try. Circ Heart Fail 6(1):23\u201330","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2807_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2048872616633877","volume":"6","author":"C Mastroianni","year":"2017","unstructured":"Mastroianni C, Bouabdallaoui N, Leprince P et al (2017) Short-term mechanical circulatory support with the Impella\u00ae 5.0 device for cardiogenic shock at La Pitie-Salpetriere. Eur Heart J Acute Cardiovasc Care 6(1):87\u201392","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2807_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40119-019-00152-8","volume":"8","author":"AV Subramaniam","year":"2019","unstructured":"Subramaniam AV, Barsness GW, Vallabhajosyula S et al (2019) Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature. Cardiol Ther 8:211\u2013228","journal-title":"Cardiol Ther"},{"key":"2807_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/2048872618805486","volume":"8","author":"DM Ouweneel","year":"2019","unstructured":"Ouweneel DM, de Brabander J, Karami M et al (2019) Real-life use of left ventricular circulatory support with Impella\u00ae in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Eur Heart J Acute Cardiovasc Care 8:338\u2013349","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"13","key":"2807_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.21037\/atm.2020.03.152","volume":"8","author":"JM Ali","year":"2020","unstructured":"Ali JM, Abu-Omar Y (2020) Complications associated with mechanical circulatory support. Ann Transl Med 8(13):835","journal-title":"Ann Transl Med"},{"issue":"10","key":"2807_CR28","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/1060028013503623","volume":"24","author":"DL Jennings","year":"2013","unstructured":"Jennings DL, Nemerovski CW, Kalus JS (2013) Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution. Ann Pharmacother 24(10):1364\u20131367","journal-title":"Ann Pharmacother"},{"issue":"4","key":"2807_CR29","doi-asserted-by":"publisher","first-page":"e1001426","DOI":"10.1371\/journal.pmed.1001426","volume":"10","author":"M Haase","year":"2013","unstructured":"Haase M, Haase-Fielitz A, Plass M et al (2013) Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicentre double-blinded randomized controlled trial. PLoS Med 10(4):e1001426","journal-title":"PLoS Med"},{"issue":"7","key":"2807_CR30","doi-asserted-by":"publisher","first-page":"e0235762","DOI":"10.1371\/journal.pone.0235762","volume":"5","author":"VV Hemradj","year":"2020","unstructured":"Hemradj VV, Karami M, Sjauw KD et al (2020) Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock. PLoS ONE 5(7):e0235762","journal-title":"PLoS ONE"},{"issue":"1","key":"2807_CR31","doi-asserted-by":"publisher","first-page":"e001214","DOI":"10.1136\/openhrt-2019-001214","volume":"7","author":"OKL Helgestad","year":"2020","unstructured":"Helgestad OKL, Josiassen J, Hassager C et al (2020) Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Open Heart 7(1):e001214","journal-title":"Open Heart"},{"issue":"4","key":"2807_CR32","doi-asserted-by":"publisher","first-page":"e0124034","DOI":"10.1371\/journal.pone.0124034","volume":"10","author":"HR Omar","year":"2015","unstructured":"Omar HR, Mirsaeidi M, Socias S et al (2015) Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS ONE 10(4):e0124034","journal-title":"PLoS ONE"},{"issue":"1","key":"2807_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joic.12080","volume":"27","author":"WW O'Neill","year":"2014","unstructured":"O\u2019Neill WW, Schreiber T, Wohns DH et al (2014) The current use of Impella\u00ae 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella registry. J Interv Cardiol 27(1):1\u201311","journal-title":"J Interv Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02807-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T08:10:31Z","timestamp":1687335031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02807-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2807"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02807-9","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"1 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}